Silverstein Christine Berni 4

What Happened Christine Berni Silverstein, a director of Abeona Therapeutics, sold 20,070 shares on 2026-02-02 in an open-market/private sale. The filing reports a weighted-average price of $5.09 for the sale, with proceeds of approximately $102,168. This was a sale (not a purchase) and was reported as done to satisfy tax obligations tied to the vesting of restricted stock awards.

Key Details

• Transaction date: 2026-02-02; Form 4 filed: 2026-02-04 (timely filing).
• Shares sold: 20,070; reported weighted-average price: $5.09; total proceeds ≈ $102,168.
• Price range: shares sold in multiple trades at prices between $5.09 and $5.12 (footnote F2).
• Reason given (footnote F1): sale to cover tax obligations associated with vesting of restricted stock awards (tax withholding).
• Shares owned after transaction: not specified in this Form 4.
• Transaction code: S = Sale.

Context Sales made specifically to cover tax withholding on vested awards are common and typically reflect tax-related liquidity needs rather than a directional view on the company. The filing offers a weighted-average price and states the seller can provide a per-trade price breakdown on request.